It should be mentioned, though, that some of the effects of FK506 have been ascribed specifically to the inhibition of FKBP51, in particular by blocking the AR and thereby inhibiting prostate cancer cell growth [229,230]. This evidence concerns the gene FKBP5 and prostate carcinoma.